How the FDA should protect its integrity
The US Food and Drug Administration (FDA) is facing criticism over whether politics is exerting an undue influence on its decisions about COVID-19 treatments. Joshua Sharfstein was acting commissioner of the agency in 2009, when it faced similar questions about undue influence. He argues that the lessons learnt then about trust and integrity are even more essential now. “Soon, amid a cacophony of misinformation and confusion, amplified by political polarization and social media, Americans will have to weigh the merits of vaccination,” says Sharfstein. “The integrity of the country’s leading public-health regulatory agency is more than an abstraction; it is a matter of life and death.”
Nature | 5 min read
No hay comentarios:
Publicar un comentario